FDA Clarifies What Information Can Be Exchanged With Health Decision-Makers
The U.S. Food and Drug Administration took significant steps to modernize how health care information is communicated. The two final guidance documents address communications questions as well as many concerns raised by NPC through our longstanding research in this area and in public testimony and comments.
Are Payers Ready to Address the Financial Challenges Associated with Gene Therapy?
In an article published on the Health Affairs Blog, NPC and the Analysis Group conducted market research and found that although payers are thinking about how to cover gene therapies, more work is needed to fully address seven important coverage challenges.